<DOC>
	<DOC>NCT02454803</DOC>
	<brief_summary>The primary purpose for this study is to understand the effect of botulinum toxin as a treatment integrated in the management of spasticity (stiffness) in the arm and/or hand, arising from any neurological condition. The study will look at the types of goals that people choose for treatment, and the extent to which these are achieved in different individuals.</brief_summary>
	<brief_title>Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<criteria>Adult patients with ULS, in whom a decision has already been made to inject botulinum toxin A (BoNT A). Patient has provided written informed consent for collection of the data. Participation in any interventional clinical study of ULS within the 12 weeks prior to the inclusion visit (Visit 1). Patient has already been included in the current study, but was subsequently withdrawn.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>